Fs-laser safe for capsulotomy creation

Article

Anterior capsulotomies may be created safely and efficaciously using a femtosecond laser system (Catalys Precision Laser System, Abbott Medical Optics), according to a study published online in the Journal of Cataract & Refractive Surgery.

Anterior capsulotomies may be created safely and efficaciously using a femtosecond laser system (Catalys Precision Laser System, Abbott Medical Optics), according to a study published online in the Journal of Cataract & Refractive Surgery.

Researchers from Moorfields Eye Hospital, London, conducted a prospective consecutive case series that evaluated 1,000 femtosecond laser–assisted cataract cases performed at the hospital between January 2013 and March 2014. During that time, platform software versions 2.15, 2.15.13, and 2.20 of the femtosecond laser system were used. The researchers evaluated the rate of complete capsulotomies that were performed without adhesions and anterior capsule tears.

The researchers found that in 998 of the 1,000 cases (99.8%), a complete 360-degree capsulotomy was present without adhesions or bridging tags. There were no cases of intraoperative tears of the anterior capsule.

There were 2 cases of incomplete capsulotomy: 1 in which the laser was aborted during the procedure and the procedure was completed manually, and 1 in which a single bridging tag adhesion occurred at capsulotomy removal, and a radial tear was identified after removal of the nucleus. The tear did not extend to the posterior capsule.

To read the abstract of the study, click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.